ChoA Pharmaceutical Co Ltd
034940
Company Profile
Business description
ChoA Pharmaceutical Co Ltd manufactures and sells medicines in South Korea. It offers products for the treatment diarrhea, duodenal ulcer, gastric ulcer, gastritis, cough, cold and others. It also provides nutrition products, health drinks, mixed drinks for children.
Contact
1 floor ACE Techno-Tower
55-7 Mullae-dong 3ga
Youngdungpo-ku
Seoul150-093
KORT: +82 221664000
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2026
Employees
275
Stocks News & Analysis
stocks
We remove our Moat Rating from ASX listed share
Despite a surging share price a weakening competitive position causes a reassessment of our view.
stocks
Best sustainable companies to own in 2026
We believe these companies’ strong ESG management practices give them a long-term advantage.
stocks
New data centre deal for ASX listed REIT
New parternship adds to a growing data centre pipeline in fiscal 2026.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,034.70 | 2.20 | -0.02% |
| CAC 40 | 8,201.99 | 6.78 | 0.08% |
| DAX 40 | 24,719.31 | 179.97 | 0.73% |
| Dow JONES (US) | 48,382.39 | 319.10 | 0.66% |
| FTSE 100 | 9,963.77 | 12.63 | 0.13% |
| HKSE | 26,347.24 | 8.77 | 0.03% |
| NASDAQ | 23,235.63 | 6.36 | -0.03% |
| Nikkei 225 | 51,832.80 | 1,493.32 | 2.97% |
| NZX 50 Index | 13,587.23 | 38.81 | 0.29% |
| S&P 500 | 6,858.47 | 12.97 | 0.19% |
| S&P/ASX 200 | 8,728.60 | 2.60 | 0.03% |
| SSE Composite Index | 4,023.42 | 54.58 | 1.38% |